The Predictive Value of Serum Inflammatory Factors High-sensitivity C-reactive Protein Combined with High Level of Lipoprotein-associated Phospholipase A2 for the Onset of Ischemic Stroke
serum Lp-PLA2, MPO, serum ferritin in Ischemic Stroke
Abstract
Objective: the aim of this article was to carried out an exploration of the predictive value of serum high-sensitivity C-reactive protein (hs-CRP) plus high levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) for the onset of ischemic stroke (IS).
Material and Method: 526 IS patients were selected as the experimental group (EG). During the same period, 463 healthy individuals served as the control group (CG). The levels of Lp-PLA2, myeloperoxidase (MPO), total cholesterol (CHO), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), hs-CRP, and serum ferritin (SF) in the serum of subjects were compared. The predictive efficacy of combination of two for the onset of IS was assessed.
Result: the levels of Lp-PLA2, MPO, CHO, LDL, TG, hs-CRP, and SF in patients with IS were all markedly higher as against the CG (P<0.05). Multivariate Logistic regression analysis (MLRA) suggested that both hs-CRP and Lp-PLA2 were independently associated with the risk of IS (OR=1.334, 95%CI=1.713~1.954; 1.251, 1.011~1.921). The ROC curve analysis revealed that the predictive efficacy for IS of hs-CRP in combination with Lp-PLA2 (area under the ROC curve (AUC)=0.786) was markedly better as against hs-CRP alone (0.713) or Lp-PLA2 alone (0.698) (P<0.05).
Conclusion: serum hs-CRP in conjunction with elevated Lp-PLA2 levels demonstrated obvious predictive value for IS, aiding in the early identification of high-risk groups.
References
Bernhardt, J., Corbett, D., Dukelow, S., Savitz, S., Solomon, J.M., Stockley, R., Sunnerhagen, K.S., Verheyden, G., Walker, M., Murphy, M.A., Bonkhoff, A.K., Cadilhac, D., Carmichael, S.T., Dalton, E., Dancause, N., Edwards, J., English, C., Godecke, E., Hayward, K., Kamalakannan, S., Kim, J., Kwakkel, G., Lang, C.E., Lannin, N., Levin, M., Lynch, E., Mead, G., Saa, J.P. and Ward, N., 2023. The international stroke recovery and rehabilitation alliance. Lancet Neurol., 22(4):295-296. https://doi.org/10.1016/S1474-4422(23)00072-8
Cani, P.D. and Delzenne, N.M., 2010. Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner. Acta Gastro Enterol. Belg., 73(2):267-269. https://doi.org/10.1007/s00261-009-9502-2
Chen, H.S., Cui, Y., Zhou, Z.H., Zhang, H., Wang, L.X., Wang, W.Z., Shen, L.Y., Guo, L.Y., Wang, E.Q., Wang, R.X., Han, J., Dong,Y.L., Li, J., Lin, Y.Z., Yang, Q.C., Zhang, L., Li, J.Y., Wang, J., Xia, L., Ma, G.B., Lu, J., Jiang, C.H., Huang, S.M., Wan, L.S., Piao, X.Y., Li, Z., Li, Y.S., Yang, K.H., Wang, D.L. and Nguyen, T.N., 2023. ARAMIS investigators. dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the aramis randomized clinical trial. JAMA., 329(24):2135-2144. https://doi.org/10.1001/jama.2023.7827
Cheng, R., Xu, X., Yang, S., Mi, Z., Zhao, Y., Wang, C., Shi, X., Gao, J., Yu, F. and Ren, X., 2023. The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA. BMC Oral Health., 23(1):85. https://doi.org/10.1186/s12903-023-02765-x
Cohen, H., Doré, C.J., Clawson, S. and Hunt, B.J., 2015. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Lupus., 24(10):1087–1094. https://doi.org/10.1177/0961203315581207
Ding, Y.L., Liu, Y., Huang, Q., Ma, L., Tian, Y.Y., Zhou, J.S. and Niu, J.L., 2022. Intravenous thrombolysis improves the prognosis of patients with acute ischemic stroke and chronic kidney disease. AMER. J. EMERG. MED., 63(2):232-238. https://doi.org/10.1016/j.jemermed.2022.05.013
Glimmerveen, A., Holewijn, S. and Vermeer, S., 2023. Association between clinician reported outcome and patient reported outcome measures one year after stroke. J. stroke cerebrovasc. dis: off. j. National Stroke Assoc., 32(8). https://doi.org/10.1016/j.jstrokecerebrovasdis.2023.107156
Jin, Z., Zhang, W., Liu, H., Ding, A., Lin, Y., Wu, S.X. and Lin, J., 2022. Potential therapeutic application of local anesthetics in cancer treatment. recent pat anticancer drug discov. 17(4):326-342. https://doi.org/10.2174/1574892817666220119121204
Ledwidge, M., Dodd, J.D., Ryan, F., Sweeney, C., McDonald, K., Fox, R., Shorten, E., Zhou, S., Watson, C., Gallagher, J., McVeigh, N., Murphy, D.J. and McDonald, K., 2023. Effect of sacubitril/valsartan vs valsartan on left atrial volume in patients with pre-heart failure with preserved ejection fraction: the parable randomized clinical trial. JAMA Cardiol., 8(4):366-375. https://doi.org/10.1001/jamacardio.2023.0065
Li, R., Mukherjee, M.B., Jin, Z., Liu, H., Lin, K., Liu, Q., Dilger, J.P. and Lin, J., 2023. The potential effect of general anesthetics in cancer surgery: meta-analysis of postoperative metastasis and inflammatory cytokines. Cancers (Basel)., 15(10):2759. https://doi.org/10.3390/cancers15102759
Liu, D., Shen, M., Liu, Z., Chen, D., Pan, Y., Zhang, L. and Xu, X., 2024. SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1. Cancer Genet., 286-287:1-10. https://doi.org/10.1016/j.cancergen.2024.05.002
Liu, F., Yang, P., Wang, Y., Shi, M., Wang, R., Xu, Q., Peng, Y., Chen, J., Zhang, J., Wang, A., Xu, T., Zhang, Y. and He, J., 2023. HS-CRP modifies the prognostic value of platelet count for clinical outcomes after ischemic stroke. J. Am. Heart. Assoc., 12(14):e030007. https://doi.org/10.1161/JAHA.123.030007
Liu, X., Zhou, W., Fan, W., Li, A., Pang, J., Chen, Z., Li, X., Hu, X., Zeng, Y. and Tang, L., 2022. The benefit of exercise rehabilitation guided by 6-minute walk test on lipoprotein-associated phospholipase A2 in patients with coronary heart disease undergoing percutaneous coronary intervention: a prospective randomized controlled study. BMC Cardiovasc Disord., 22(1):177. https://doi.org/10.1186/s12872-021-02430-7
Magnoli, F., Marchiori, D., Facchi, S., Martin, V., Campiotti, L., Merli, M., Sessa, F., Tibiletti, M.G. and Uccella, S., 2023. High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy. Cancer Genet., 274-275:1-9. https://doi.org/10.1016/j.cancergen.03.001
Schaeff, V.L.K., Sperber, P.S., Piper, S.K., Giesers, N.K., Gertz, K., Heuschmann, P.U., Endres, M. and Liman, T.G., 2024. Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort. J. Neurol., 271(2):909-917. https://doi.org/10.1007/s00415-023-12038-w
Siddiqui, M.K., Smith, G., St Jean, P., Dawed, A.Y., Bell, S., Soto-Pedre, E., Kennedy, G., Carr, F., Wallentin, L., White, H., Macphee, C.H., Waterworth, D., Palmer, C.N.A., 2022. Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events. Diabetologia., 65(1):101-112. https://doi.org/10.1007/s00125-021-05574-5
Thakkar, R., Pedraza, D.A.O. and Yavagal, D.R., 2023. Abstract tp243: efficacy of intra-arterial stem cell therapy in a canine model of ischemic stroke: role of anti-inflammatory action in the brain. Stroke., 54(Suppl_1):ATP243-ATP243. https://doi.org/10.1161/str.54.suppl_1.TP243
Tian, Y., Lu, L., Zhang, Y. and Wei, J., 2024. The value of Lp(a) and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke. Brain Behav. 14(1):e3355. https://doi.org/10.1002/brb3.3355
Tian, Y., Lu, L., Zhang, Y. and Wei, J., 2024. The value of Lp(a) and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke. Brain Behav. 14(1):e3355. https://doi.org/10.1002/brb3.3355
Wada, Y., Jensen, C., Meyer, A.S.P., Zonoozi, A.A.M. and Honda, H., 2023. Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial. J. Cardiol., 82(4):279-285. https://doi.org/10.1016/j.jjcc.2023.05.006
Xi, H., Cheng, G.L., Hu, F.F., Li, S.N., Deng, X. and Zhou, Y., 2022. The use of lipoprotein-associated phospholipase a2 in a chinese population to predict cardiovascular events. Biomed Environ Sci., 35(3):206-214. https://doi.org/10.3967/bes2022.029
Xu, L., Duan, J., Li, M., Zhou, C. and Wang, Q., 2023. Circ_0000253 promotes the progression of osteosarcoma via the miR-1236-3p/SP1 axis. J. Pharm Pharmacol., 75(2):227-235. https://doi.org/10.1093/jpp/rgac081
Yu, B., Shi, G., Yang, F. and Xu, W., 2024. Correlation of LP-PLA2 and MMP-9 with the occurrence of early neurological deterioration in patients with acute ischemic stroke. Med. (Baltimore)., 103(21):e38310. https://doi.org/10.1097/MD.0000000000038310
Zaira, B., Yulianti, T. and Levita, J., 2024. Correlation of hepatocyte growth factor (HGF) and high sensitivity C-reactive protein (hs-CRP) in long-term COVID-19. Clin. Chim. Acta, 558. 8. https://doi.org/10.1016/j.cca.2024.119118
Zhang, Q., Wang, X., Zheng, J., Lü, Q., Li, R., Jia, X. and Gu, M., 2023. Heterozygous variants of NOD2, IL10RA, PLA2G6 and COL7A1 correlate with Crohn's disease. Heliyon., (1):e22968. https://doi.org/10.1016/j.heliyon.2023.e22968
Zhang, X., Liu, L., Jiang, N., Liu, Y., Wang, Q., Tang, X., Zhai, Q. and Zhao, L., 2022. Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke. BMC Neurol., 22(1):482. https://doi.org/10.1186/s12883-022-03000-w
Zheng, Y., Ren, Z., Liu, Y., Yan, J., Chen, C., He, Y., Shi, Y., Cheng, F., Wang, Q., Li, C. and Wang, X., 2024. T cell interactions with microglia in immune-inflammatory processes of ischemic stroke. Neural Regen Res., 20(5):1277-1292. https://doi.org/10.4103/NRR.NRR-D-23-01385
Zhong, X., Ao, Q. and Xing, F., 2022. Serum levels of hcy, mif, and hs-crp correlate with glycolipid metabolism in adults with never-medicated first-episode schizophrenia. Evid. Based Complement Alternat Med., 2023:9803064. https://doi.org/10.1155/2021/7394699
Copyright (c) 2025 Yaojin Zuo
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.